Results 151 to 160 of about 20,942,428 (379)
Molecular Oncology, EarlyView.In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen +13 more
wiley +1 more source
Relaxation for partially coercive integral functionals with linear growth [PDF]
We prove an integral representation theorem for the $\mathrm{L}^1$-relaxation of the functional $\mathcal{F}\colon u\mapsto\int_\Omega f(x,u(x),\nabla u(x))\;\mathrm{d} x,\quad u\in\mathrm{W}^{1,1}(\Omega;\mathbb{R}^m)$, where $\Omega\subset\mathbb{R}^d$
Rindler, Filip, Shaw, Giles
core +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
The Decadence of Law as a Profession and Its Growth as a Business [PDF]
, 1903 Robert Treat Platt
openalex +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
The Structure and Growth of Residential Neighborhoods in American Cities
, 1940 Walter J. Matherly, Homer Hoyt
openalex +2 more sources
A CASE OF SECONDARY CARCINOMATOUS GROWTHS SIMULATING TUBERCULOUS HIP-JOINT DISEASE AND MILIARY TUBERCULOSIS [PDF]
, 1906 R. E. Lord, Chas. W. Buckley
openalex +1 more source
Molecular Oncology, EarlyView.This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke +12 more
wiley +1 more source
Increasing Returns and Long-Run Growth
Journal of Political Economy, 1986 P. Romer
semanticscholar +1 more source